MKM Partners Hires Senior Travel Analyst as the Firm Continues to Expand Its Research Department at New Corporate Headquarters prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
In a research report published by Dahlman Rose & Co. this morning the Danaos Corporation s (NYSE: DAC) 3Q10 results are reviewed.
Dahlman Rose & Co. writes, Danaos reported 3Q10 earnings of $0.05 ex-items, lower than our $0.10 and the Street s $0.09 average estimate. The company continues. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
E&P Picks for 2021: Good Free Cash Flow, No Geopolitical Issues
Neal Dingmann is a Managing Director at Truist Securities covering companies in the E&P and oilfield services sectors. He has over a dozen years of equity research experience. Prior, he held similar positions at Wunderlich Securities, Dahlman Rose, RBC Capital and Bank of America Securities. Dingmann was recognized by
The Wall Street Journal as “Best on the Street” and has been recognized as a “Home Run Hitter” by
Institutional Investor magazine. He received an MBA from the University of Minnesota and a B.A. degree in business from the University of Arkansas. Profile
February 5, 2021
Senior Vice President equity research for Wunderlich Securities
Neal Dingmann is a Managing Director at Truist Securities covering companies in the E&P and oilfield services sectors. Mr. Dingmann was recognized by
The Wall Street Journal as “Best on the Street” and has been recognized as a “Home Run Hitter” by
Institutional Investor magazine.
He has over a dozen years of equity research experience.
Prior, he held similar positions at Wunderlich Securities, Dahlman Rose, RBC Capital and Bank of America Securities. He received an MBA from the University of Minnesota and a B.A. degree in business from the University of Arkansas.
Aegis Capital Corp. announces the hiring of a new Director of Healthcare Research
Aegis Capital Corp. (
announce Chrishan Anketell has joined the firm as a Director of Healthcare Research
Chrishan Anketell has extensive experience in sell-side equity and fixed income fundamental analysis covering a wide variety of sectors including Medical Devices, Healthcare Services, Biotech, Cleantech and Technology. Mr. Anketell started his career as a Market Research Associate at FTN Midwest Research and has since worked on several highly ranked equity research teams by Institutional Investor and Starmine. Prior to joining Aegis, Chrishan has worked in the equity research capacity at Dahlman Rose & Company, MKM Partners LLC, Northcoast Research Partners and Roth Capital Partners. Throughout his career, Mr. Anketell has been very successful in building solid relationships with industry specialists through intensive channel checks and weekly conference calls. Chrishan was also responsible for i